Boyds bolsters clinical operations team with appointment of Kathryn Bartley

Pharmaceutical and biotech product development consultancy Boyds has recruited Kathryn Bartley as Senior Clinical Research Associate.

The appointment follows last year’s acquisition of Blue Duck Consultancy which fueled the expansion of Boyds’ in-house clinical and medical affairs services offering.

Kathryn has over 18 years’ experience in the industry, primarily in study and site management and monitoring. Her work has covered a variety of therapy areas across all trial phases within both the commercial and academic sectors.

Most recently, Kathryn spent six years working for GlaxoSmithKline (subcontracted from Parexel and then PPD) as a Senior Clinical Research Associate working primarily on real world evidence respiratory studies, including the ground-breaking Salford Lung Studies (SLS). Kathryn’s experience also includes working as a remote Clinical Research Associate on oncology trials at AstraZeneca, as well as four years as a Study Manager at the University of Liverpool Cancer Research UK Trials Unit setting up and managing haematological oncology studies.

Commenting on her appointment, Kathryn said: “Boyds is a fast-growing company with a strong reputation in the industry. I am excited to be part of their growth ambitions to expand their clinical services team. I am looking forward to working with and learning from the fantastic team of experts at Boyds, as well as building on my knowledge in advanced therapies.”

Vice President of Clinical Operations at Boyds, Dr Karen O’Hanlon added: “We are delighted to welcome Kathryn to the team. We have an established international network of consultant CRAs and our ambition is to build on this by creating an in-house team. Kathryn brings a wealth of experience and will be instrumental in supporting the growth of our clinical and medical affairs offering.

“Boyds is pretty unique in the industry offering project management and regulatory support and expertise from early stage discovery and development all the way through to clinical trials and commercialisation. Our Clinical Operations team, and network of consultant CRAs, are experienced in ATMPs and cutting-edge trials. This expertise, combined with our focus on the strategy as well as the operations in the development of medicines is an attractive offering to our clients.”

Kathryn will be based in Boyds’ Crewe office, and her role will involve performing all aspects of site set-up and management including pre-study, initiation, monitoring and closeout visits; stand-alone ethics submissions, feasibility studies, medical writing and training.

Boyds won the Queen’s Award for Enterprise, International Trade for Outstanding Short-Term Growth in overseas sales in April 2018 and was the Business of the Year in the South Cheshire Chamber Awards 2019.

-Ends –


Notes to editors: 

About Boyds

Boyds (trading name of Boyd Consultants) was established in 2005 by Professor Alan Boyd and provides a range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices.

Based in the UK and Ireland with offices in Cheshire, Cambridgeshire and Dublin, Boyds has an international client base comprising of early stage life science and medical devices companies as well as Universities. In 2018, Boyds was awarded the prestigious Queen’s Award for Enterprise, International Trade for outstanding short-term growth in overseas sales, and in recognition for its work in cell and gene therapy.

Expertise includes: small molecules NCEs; advanced therapies including cell & gene therapy; tissue engineering; recombinant proteins; protein conjugates; antibodies; biosimilars; parenteral, oral and topical dose forms; medical devices; IVDs.

Professional Services include: product development; statistics and data management; regulatory affairs; regulatory medical writing; clinical and medical affairs including medical monitoring support; business support; training.

In 2018, Boyds Training was launched following the acquisition of BaxterBoyd to provide a modular training programme in Pharmaceutical Medicine.

For more information, please visit our website

Media Contact Information: 

For further information, please contact: Sue Carr on 07809 727533, email: